candesartan has been researched along with perindopril in 26 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 16 (61.54) | 29.6817 |
| 2010's | 8 (30.77) | 24.3611 |
| 2020's | 2 (7.69) | 2.80 |
| Authors | Studies |
|---|---|
| Funakoshi, J; Kakumoto, M; Okumura, K; Sakaeda, T; Takara, K; Tanigawara, Y | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Iwao, H; Izumi, Y; Kim, S; Zhan, Y | 1 |
| Fukui, H; Ikenaka, Y; Kuriyama, S; Nakatani, T; Noguchi, R; Tsujinoue, H; Yoshii, J; Yoshiji, H | 1 |
| Fusshöller, A; Grabensee, B; Hermsen, D; Hetzel, GR; Hohlfeld, T; Ozcan, F; Plum, J; Rettich, A | 1 |
| Ciccarelli, L; Cicero, AF; Derosa, G; Fogari, R; Mugellini, A | 1 |
| Ikeda, U; Kurosaki, K; Murakami, Y; Shimada, K; Takahashi, M | 1 |
| Ciccarelli, L; Cicero, AF; Derosa, G; Fogari, R | 1 |
| Ikeda, U; Kurosaki, K; Matsui, K; Murakami, Y; Shimada, K | 1 |
| Owen, OG | 1 |
| Hayashi, K; Homma, K; Kanda, T; Matsuda, H; Saruta, T; Takamatsu, I; Tatematsu, S; Wakino, S; Yoshioka, K | 1 |
| Fukui, H; Ikenaka, Y; Kitade, M; Kuriyama, S; Namisaki, T; Noguchi, R; Tsujinoue, H; Yamazaki, M; Yanase, K; Yoshii, J; Yoshiji, H | 1 |
| Horikoshi, K; Izumi, T; Mochizuki, S; Nagai, M; Seki, S; Taniguchi, I; Taniguchi, M | 1 |
| Kinugawa, S | 1 |
| Nesbitt, SD | 1 |
| Jenkins, TA | 1 |
| Amann, K; Boor, P; Heidland, A; Lill, M; Sebeková, K | 1 |
| Baron-Menguy, C; Cousin, M; Custaud, MA; Dumont, O; Guihot, AL; Henrion, D; Loufrani, L; Subra, JF; Toutain, B; Vessières, E | 2 |
| Fujii, Y; Iimura, Y; Kawakami, S; Kihara, K; Koga, F; Masuda, H; Matsuoka, Y; Saito, K; Tatokoro, M | 1 |
| Agrawal, H; Albaghdadi, A; Bramblett, T; Mukherjee, D; Teleb, M | 1 |
| Kikuchi, Y; Kobayashi, M; Momomura, S; Mutoh, A; Ueda, S; Wada, H; Yasu, T | 1 |
| Cai, Y; Deng, H; Feng, Q; Li, Z; Qiu, S; Tian, W; Wang, X; Wang, Y; Wu, J | 1 |
| Rickenbacher, P | 1 |
| Briasouli, A; Briasoulis, A; Fujisaki, T; Kuno, T; Takagi, H; Ueyama, H | 1 |
| Tchernev, G | 1 |
6 review(s) available for candesartan and perindopril
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
[Diabetic heart disease].
Topics: Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Benzimidazoles; Biphenyl Compounds; Diabetes Complications; Diabetes Mellitus; Diabetic Angiopathies; Diabetic Neuropathies; Heart Failure; Humans; Insulin Resistance; Myocardial Contraction; Myocardial Infarction; Perindopril; Tetrazoles; Ventricular Remodeling | 2007 |
Antihypertensive combination therapy: optimizing blood pressure control and cardiovascular risk reduction.
Topics: Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Benzimidazoles; Biphenyl Compounds; Blood Pressure; Calcium Channel Blockers; Cardiovascular Diseases; Diuretics; Drug Therapy, Combination; Humans; Perindopril; Tetrazoles; Treatment Outcome | 2007 |
Heart Failure with Preserved Ejection Fraction: Entresto a Possible Option.
Topics: Aminobutyrates; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Benzimidazoles; Biphenyl Compounds; Clinical Trials as Topic; Drug Combinations; Heart; Heart Failure; Humans; Irbesartan; Perindopril; Tetrazoles; Valsartan | 2017 |
[Heart failure with "mid-range" ejection fraction: a new clinical entity?]
Topics: Aged; Aminobutyrates; Benzimidazoles; Biomarkers; Biphenyl Compounds; Comorbidity; Coronary Disease; Drug Combinations; Drug Therapy, Combination; Evidence-Based Medicine; Heart Failure; Humans; Natriuretic Peptides; Perindopril; Prognosis; Randomized Controlled Trials as Topic; Risk Factors; Spironolactone; Stroke Volume; Survival Rate; Syndrome; Tetrazoles; Valsartan | 2018 |
Meta-Analysis Evaluating the Effects of Renin-Angiotensin-Aldosterone System Blockade on Outcomes of Heart Failure With Preserved Ejection Fraction.
Topics: Aminobutyrates; Angiotensin II Type 1 Receptor Blockers; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Benzimidazoles; Biphenyl Compounds; Cardiovascular Diseases; Drug Combinations; Heart Failure; Hospitalization; Humans; Irbesartan; Mineralocorticoid Receptor Antagonists; Mortality; Network Meta-Analysis; Perindopril; Randomized Controlled Trials as Topic; Renin-Angiotensin System; Spironolactone; Stroke Volume; Tetrazoles; Treatment Outcome; Valsartan | 2020 |
5 trial(s) available for candesartan and perindopril
| Article | Year |
|---|---|
Inhibition of the renin-angiotensin system: no effect on circulating macrophage colony-stimulating factor levels in acute myocardial infarction.
Topics: Adult; Aged; Aged, 80 and over; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Benzimidazoles; Biphenyl Compounds; Female; Humans; Macrophage Colony-Stimulating Factor; Male; Middle Aged; Myocardial Infarction; Perindopril; Renin-Angiotensin System; Tetrazoles; Treatment Outcome | 2003 |
A randomized, double-blind, controlled, parallel-group comparison of perindopril and candesartan in hypertensive patients with type 2 diabetes mellitus.
Topics: Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Benzimidazoles; Biphenyl Compounds; Blood Glucose; Diabetes Mellitus, Type 2; Double-Blind Method; Female; Humans; Hypertension; Lipoproteins; Male; Middle Aged; Perindopril; Tetrazoles | 2003 |
Serum MCP-1 and VEGF levels are not affected by inhibition of the renin-angiotensin system in patients with acute myocardial infarction.
Topics: Aged; Aged, 80 and over; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Benzimidazoles; Biphenyl Compounds; Chemokine CCL2; Enzyme-Linked Immunosorbent Assay; Female; Humans; Male; Middle Aged; Monocytes; Myocardial Infarction; Perindopril; Renin-Angiotensin System; Tetrazoles; Vascular Endothelial Growth Factor A | 2003 |
Differing anti-proteinuric action of candesartan and losartan in chronic renal disease.
Topics: Adult; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Benzimidazoles; Biphenyl Compounds; Blood Pressure; Female; Humans; Kidney Failure, Chronic; Losartan; Male; Middle Aged; Nitric Oxide; Perindopril; Proteinuria; Tetrazoles | 2003 |
Phase-II trial of combination treatment of interferon-α, cimetidine, cyclooxygenase-2 inhibitor and renin-angiotensin-system inhibitor (I-CCA therapy) for advanced renal cell carcinoma.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Benzimidazoles; Biphenyl Compounds; Carcinoma, Renal Cell; Cimetidine; Cyclooxygenase 2 Inhibitors; Disease-Free Survival; Female; Humans; Interferon-alpha; Kidney Neoplasms; Male; Middle Aged; Perindopril; Tetrazoles | 2011 |
15 other study(ies) available for candesartan and perindopril
| Article | Year |
|---|---|
Interaction of digoxin with antihypertensive drugs via MDR1.
Topics: Animals; Antihypertensive Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; Biological Transport; Cells, Cultured; Digoxin; Drug Interactions; Humans; Time Factors | 2002 |
Cardiovascular effects of combination of perindopril, candesartan, and amlodipine in hypertensive rats.
Topics: Adrenergic beta-Antagonists; Amlodipine; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Angiotensins; Animals; Antihypertensive Agents; Aorta; Atrial Natriuretic Factor; Benzimidazoles; Biphenyl Compounds; Blood Pressure; Bradykinin; Calcium; Calcium Channel Blockers; Drug Therapy, Combination; ErbB Receptors; Gene Expression; Heart Ventricles; Hypertension; Myocardium; Organ Size; Perindopril; Phosphorylation; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Receptors, Angiotensin; Receptors, Platelet-Derived Growth Factor; RNA, Messenger; Stroke; Tetrazoles | 2000 |
Angiotensin-II type 1 receptor interaction is a major regulator for liver fibrosis development in rats.
Topics: Angiotensin II; Animals; Benzimidazoles; Biphenyl Compounds; Endothelial Growth Factors; Immunohistochemistry; Liver Cirrhosis, Experimental; Lymphokines; Male; Perindopril; Rats; Rats, Inbred F344; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Receptors, Angiotensin; Renin-Angiotensin System; RNA, Messenger; Tetrazoles; Transforming Growth Factor beta; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factors | 2001 |
Effects of candesartan and perindopril on renal function, TGF-beta1 plasma levels and excretion of prostaglandins in stable renal allograft recipients.
Topics: Adult; Aged; Albuminuria; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Benzimidazoles; Biphenyl Compounds; Creatinine; Dose-Response Relationship, Drug; Follow-Up Studies; Humans; Kidney; Kidney Transplantation; Middle Aged; Perindopril; Prostaglandins; Tetrazoles; Transforming Growth Factor beta; Transforming Growth Factor beta1; Treatment Outcome | 2002 |
Perindopril and candesartan comparative efficacy and safety in type II diabetic hypertensive patients.
Topics: Antihypertensive Agents; Benzimidazoles; Biphenyl Compounds; Clinical Trials as Topic; Diabetes Mellitus, Type 2; Female; Humans; Hypertension; Male; Perindopril; Tetrazoles; Treatment Outcome | 2003 |
EUROPA shows role for ACE inhibition in low-risk CHD.
Topics: Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Benzimidazoles; Biphenyl Compounds; Coronary Disease; Female; Heart Failure; Humans; Male; Middle Aged; Perindopril; Tetrazoles; Treatment Outcome | 2003 |
Combination of interferon-beta and angiotensin-converting enzyme inhibitor, perindopril, attenuates the murine liver fibrosis development.
Topics: Actins; Angiotensin-Converting Enzyme Inhibitors; Animals; Antiviral Agents; Benzimidazoles; Biomarkers; Biphenyl Compounds; Cell Proliferation; Collagen Type I; Disease Models, Animal; Drug Synergism; Drug Therapy, Combination; Hydroxyproline; Interferon-beta; Kupffer Cells; Liver; Liver Cirrhosis, Experimental; Male; Mice; Mice, Inbred BALB C; Perindopril; Rats; Rats, Inbred F344; RNA, Messenger; Tetrazoles | 2005 |
Cardioprotective action of perindopril versus candesartan in renovascular hypertensive rats.
Topics: Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Animals; Benzimidazoles; Biphenyl Compounds; Blood Pressure; Cardiomegaly; Dose-Response Relationship, Drug; Hypertension, Renovascular; Male; Perindopril; Rats; Rats, Wistar; Renin-Angiotensin System; Tetrazoles | 2004 |
Effect of angiotensin-related antihypertensives on brain neurotransmitter levels in rats.
Topics: Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Animals; Benzimidazoles; Biphenyl Compounds; Brain; Dopamine; Male; Neurotransmitter Agents; Norepinephrine; Perindopril; Rats; Serotonin; Tetrazoles | 2008 |
Functional and partial morphological regression of established renal injury in the obese zucker rat by blockade of the renin-angiotensin system.
Topics: Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Animals; Benzimidazoles; Biphenyl Compounds; Blood Pressure; Body Weight; Diabetic Nephropathies; Kidney Function Tests; Kidney Glomerulus; Male; Organ Size; Oxidative Stress; Perindopril; Proteinuria; Random Allocation; Rats; Rats, Zucker; Tetrazoles | 2009 |
Role of angiotensin II in the remodeling induced by a chronic increase in flow in rat mesenteric resistance arteries.
Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Animals; Antioxidants; Benzimidazoles; Biphenyl Compounds; Blood Flow Velocity; Blotting, Western; Butadienes; Cyclic N-Oxides; Extracellular Signal-Regulated MAP Kinases; Hydralazine; Male; Mesenteric Arteries; Mice; Mice, Knockout; Microscopy, Confocal; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase Type III; Nitriles; Perindopril; Rats; Rats, Wistar; Reactive Oxygen Species; Spin Labels; Tetrazoles; Vascular Resistance; Vasodilator Agents | 2010 |
Involvement of angiotensin II in the remodeling induced by a chronic decrease in blood flow in rat mesenteric resistance arteries.
Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Animals; Benzimidazoles; Biphenyl Compounds; Blood Flow Velocity; Chronic Disease; Extracellular Signal-Regulated MAP Kinases; Hypertension; Mesenteric Arteries; Mice; Mice, Knockout; Nitric Oxide Synthase Type III; Perindopril; Rats; Rats, Wistar; Reactive Oxygen Species; Tetrazoles; Vascular Resistance; Vasoconstriction; Vasoconstrictor Agents | 2010 |
Renin-Angiotensin System Inhibitors Can Prevent Intravenous Lipid Infusion-Induced Myocardial Microvascular Dysfunction and Leukocyte Activation.
Topics: Adult; Benzimidazoles; Biphenyl Compounds; Coronary Circulation; Cross-Over Studies; Double-Blind Method; Endothelium, Vascular; Fatty Acids, Nonesterified; Humans; Hyperemia; Lipids; Lymphocyte Activation; Male; Microcirculation; NF-KappaB Inhibitor alpha; Oxidative Stress; Perindopril; Renin-Angiotensin System; Tetrazoles; Young Adult | 2018 |
Ultrasound-Stimulated Microbubbles Enhance Radiosensitization of Nasopharyngeal Carcinoma.
Topics: Angiotensin II; Animals; Antigens, CD34; Benzimidazoles; Biphenyl Compounds; Carcinoma; Cell Line, Tumor; Cell Proliferation; Cell Survival; Contrast Media; Female; Gamma Rays; Human Umbilical Vein Endothelial Cells; Humans; Mice; Mice, Nude; Microbubbles; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Perindopril; Receptor, Angiotensin, Type 1; Sonication; Tetrazoles | 2018 |
THE NITROSAMINE CONTAMINATION IN BETA BLOCKERS (BISOPROLOL/METOPROLOL), ACE INHIBITORS (LISINOPRIL/PERINDOPRIL), THIAZIDES DIURETICS (HCT), CALCIUM CHANNEL BLOCKERS (AMLODIPINE/FELODIPINE), SARTANS (CANDESARTAN) AND ТHE SUBSEQUENT SKIN CANCER DEVELOPMENT
Topics: Amlodipine; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Bisoprolol; Calcium; Calcium Channel Blockers; Diabetes Mellitus, Type 2; Felodipine; Humans; Lisinopril; Melanoma; Metoprolol; Nitrosamines; Perindopril; Prospective Studies; Skin Neoplasms; Sodium Chloride Symporter Inhibitors; Thiazides | 2023 |